AI-Pathway Companion applications are not commercially available in all countries. Their future availability cannot be guaranteed.
AI-Pathway Companion Prostate Cancer VA10B/VC10A is CE-compliant in accordance with Directive 93/42/EEC.
AI-Pathway Companion Breast Cancer, AI-Pathway Companion Coronary Artery Disease, and AI-Pathway Companion Infectious Diseases are under development and not commercially available. Its future availability cannot be ensured.
Prerequisite: “All data is available as required per guideline.”; Feature dependent on quality of input data.
AI-Pathway Companion Lung Cancer VA10A supports single primary tumor and non-small cell Lung cancer cases only.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
This function is supported by AI-Pathway Companion Connector.
The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.
Physician is employed by an institution that receives financial support from Siemens Healthineers for collaborations.
AI-Pathway Companion Prostate Cancer is not commercially available in all countries. Its future availability cannot be guaranteed.
AI-Pathway Companion Prostate Cancer supports prostate cancer adenocarcinoma cases only.
AI-Pathway Companion Prostate Cancer supports prostate cancer guidelines by NCCN and EAU only.
This function is supported by AI-Pathway Companion Analytics.